[1] Moreau R,Jalan R,Gines P,et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.Gastroenterology,2013,144:1426-1437.1437.e1-9.
[2] Dionigi E,Garcovich M,Borzio M,et al.Bacterial infections change natural history of cirrhosis irrespective of liver disease severity.Am J Gastroenterol,2017,112:588-596.
[3] Schmidt ML,Barritt AS,Orman ES,et al.Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.Gastroenterology,2015,148:967-977.e2.
[4] Kumar R,Mehta G,Jalan R.Acute-on-chronic liver failure.Clin Med (Lond),2020,20:501-504.
[5] Trebicka J,Fernandez J,Pap M,et al.The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.J Hepatol,2020,73(4):842-854.
[6] Wiest R,Krag A,Gerbes A.Spontaneous bacterial peritonitis:recent guidelines and beyond.Gut,2012,61:297-310.
[7] Piano S,Singh V,Caraceni P,et al.Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide.Gastroenterology,2019,156:1368-1380.e10.
[8] Roccarina D,Rosselli M,Genesca J,et al.Elastography methods for the non-invasive assessment of portal hypertension.Expert Rev Gastroenterol Hepatol,2018,12:155-164.
[9] Asrani SK,Devarbhavi H,Eaton J,et al.Burden of liver diseases in the world.J Hepatol,2019,70:151-171.
[10] Shah S,Goldberg DS,Kaplan DE,et al.Patient frailty is independently associated with the risk of acute on chronic liver failure hospitalization.Liver Transpl,2020,Sep 18.
[11] Duseja A,DeA,Taneja S,et al.Impact of metabolic risk factors on the severity and outcome of patients with alcohol associated acute-on-chronic liver failure.Liver Int,2020 Sep 24.
[12] Arshad A,Irshad L,Nabavi T,et al.Acute-on-chronic liver failure:to admit to intensive care or not Br J Hosp Med(Lond ),2020,81(9):1-6
[13] Manka P,Canbay A,Bechmann LP.Model for end-stage liver disease-sodium in acute-on-chronic liver failure.J Hepatol,2020,73:1578-1579.
[14] Cullaro G,Sharma R,Trebicka J,et al.Precipitants of acute-on-chronic liver failure:an opportunity for preventative measures to improve outcomes.Liver Transpl,2020,26:283-293.
[15] Fernández J,Angeli P,Trebicka J,et al.Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis.Clin Gastroenterol Hepatol,2020,18:963-973.e14.
[16] Caraceni P,Riggio O,Angeli P,et al.Long term albumin administration in decompensated cirrhosis(ANSWER ):an open-label randomised trial.Lancet,2018,391:2417-2429.
[17] Bernardi M,Angeli P,Claria J,et al.Albumin in decompensated cirrhosis:new concepts and perspectives.Gut,2020,69:1127-1138.
[18] O'Brien A,Karvellas CJ.Acute-on-chronic liver failure:The challenge of PREDICTing who and when.J Hepatol,2020,https://doi.org/10.1016/j.jhep.2020.06.013
[19] European Association for the Study of the Liver.EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis.J Hepatol,2018,69:406-460. |
